In 2018, the 12th Otto Roelen Medal will be awarded for an outstanding achievement in catalysis research. DECHEMA and the German Catalysis Society (GeCatS) invite researchers and scientists to propose international candidates who have made significant contributions in this field, especially with regard to application-oriented research.
The Otto Roelen Medal is endowed with 5,000 Euro and sponsored by the Oxea Group. Nominations will be evaluated by the Expert Committee of the Otto Roelen Medal.
The prize will be awarded in a public ceremony at the Annual Meeting of German Catalysis Researchers in March 2018 in Weimar/Germany.
Proposals for nominations should be submitted before 15th September 2017.
Proposals should be accompanied by a detailed justification, the candidate’s CV and a list of publications and patents. Submission of exemplary publications in internationally renowned scientific journals as well as reference letters from industry is also appreciated. Self-nominations are not accepted.
The Otto Roelen Medal was initiated in 1997 by Hoechst AG and is named after the discoverer of hydroformulation.
Originally limited to the field of homogeneous catalysis, the prize is now open to international researchers in the whole field of catalysis.
Former award-winners include Prof. Dr. Matthias Beller, Institut für Organische Katalyseforschung (1997), Prof. Dr. Kay Severin, ETH Lausanne/CH (2005), Prof. Dr. Michael Buchmeiser, Universität Stuttgart (2010), Prof. Dr. Javier Pérez-Ramírez, ETH Zürich/CH (2012), Prof. Dr. Harald Gröger, University of Bielefeld (2014) and Prof. Dr. Peter Strasser, TU Berlin (2016).
Dr. Kathrin Rübberdt | idw - Informationsdienst Wissenschaft
13.11.2018 | Albert-Ludwigs-Universität Freiburg im Breisgau
Improving the understanding of death receptor functions in cells
07.11.2018 | Goethe-Universität Frankfurt am Main
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
What if a sensor sensing a thing could be part of the thing itself? Rice University engineers believe they have a two-dimensional solution to do just that.
Rice engineers led by materials scientists Pulickel Ajayan and Jun Lou have developed a method to make atom-flat sensors that seamlessly integrate with devices...
Scientists at the University of Stuttgart and the Karlsruhe Institute of Technology (KIT) succeed in important further development on the way to quantum Computers.
Quantum computers one day should be able to solve certain computing problems much faster than a classical computer. One of the most promising approaches is...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
12.12.2018 | Health and Medicine
12.12.2018 | Physics and Astronomy
12.12.2018 | Health and Medicine